Anabolic ergogenic substance users in fitness-sports: A distinct group supported by the health care system

被引:92
作者
Striegel, H
Simon, P
Frisch, S
Roecker, K
Dietz, K
Dickhuth, HH
Ulrich, R
机构
[1] Univ Tubingen, Dept Sports Med, D-72076 Tubingen, Germany
[2] Univ Tubingen, Inst Brain Res, D-72076 Tubingen, Germany
[3] Univ Freiburg, Dept Sports Med, D-79106 Freiburg, Germany
[4] Univ Tubingen, Dept Med Biometry, D-72070 Tubingen, Germany
[5] Univ Tubingen, Inst Psychol, D-72072 Tubingen, Germany
关键词
anabolic ergogenic substance use; illicit drug use; health care system; prevention; doping;
D O I
10.1016/j.drugalcdep.2005.05.013
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background:: Anabolic ergogenic substance use, in particular the use of anabolic androgenic steroids, is a serious problem in general. Nevertheless, it is subject to debate whether ergogenic substance users exhibit similar features as multiple substance users or whether they constitute a discrete group. Methods:: One thousand eight hundred and two standardized, anonymous questionnaires were distributed among visitors of 113 fitness centers. Questions were asked concerning biometric parameters, social indicators, physical fitness, use of natural stimulants, general illicit drugs and ergogenic substances. With logistic regression analysis, multivariate odds ratios were estimated to investigate the association of anabolic ergogenic substance or general illicit drug use with other parameters. Results:: 13.5% of all participants confessed to having used anabolic ergogenic substances at some point in time. Anabolic ergogenic substance use was positively related with cocaine use, training years, training frequency, negatively related to the level of education, alcohol intake and less frequently used by Germans than by non-Germans. General illicit drug use. however, was positively related with alcohol intake, smoking and a university degree and negatively with having children. In addition, anabolic ergogenic substance use was significantly related with the use of general illicit drugs based on the strong relation with the use of cocaine, which is an ergogenic substance itself. The health care system supplies 48.1% of the anaolic ergogenic substance users with their substances and 32.1% are even monitored by a physician. Conclusions:: The results of this study strengthen the notion that anabolic ergogenic substance users constitute a specific body-oriented substance user group. Uncommon for general illicit drug use, the health care system is a major sponsor of anabolic ergogenic substance users. These findings suggest the need for alternative approaches for successful prevention and intervention programs. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:11 / 19
页数:9
相关论文
共 28 条
  • [1] Anabolic-androgenic steroids as a gateway to opioid dependence
    Arvary, D
    Pope, HG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (20) : 1532 - 1532
  • [2] Risk factors associated with anabolic-androgenic steroid use among adolescents
    Bahrke, MS
    Yesalis, CE
    Kopstein, AN
    Stephens, JA
    [J]. SPORTS MEDICINE, 2000, 29 (06) : 397 - 405
  • [3] ANABOLIC-STEROID ABUSE AND RENAL-CELL CARCINOMA
    BRYDEN, AAG
    ROTHWELL, PJN
    OREILLY, PH
    [J]. LANCET, 1995, 346 (8985) : 1306 - 1307
  • [4] BUCKLEY WE, 1988, JAMA-J AM MED ASSOC, V260, P3441
  • [5] STABILITY OF THE RELATIONSHIPS BETWEEN ANABOLIC-STEROID USE AND MULTIPLE SUBSTANCE USE AMONG ADOLESCENTS
    DURANT, RH
    ASHWORTH, CS
    NEWMAN, C
    RICKERT, VI
    [J]. JOURNAL OF ADOLESCENT HEALTH, 1994, 15 (02) : 111 - 116
  • [6] USE OF MULTIPLE-DRUGS AMONG ADOLESCENTS WHO USE ANABOLIC-STEROIDS
    DURANT, RH
    RICKERT, VI
    ASHWORTH, CS
    NEWMAN, C
    SLAVENS, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (13) : 922 - 926
  • [7] Flow-mediated, endothelium-dependent vasodilatation is impaired in male body builders taking anabolic-androgenic steroids
    Ebenbichler, CF
    Sturm, W
    Gänzer, H
    Bodner, J
    Mangweth, B
    Ritsch, A
    Sandhofer, A
    Lechleitner, M
    Föger, B
    Patsch, JR
    [J]. ATHEROSCLEROSIS, 2001, 158 (02) : 483 - 490
  • [8] FREUD S, 1884, CENTRALBLATT GESAMMT, P289
  • [9] Effects of a multidimensional anabolic steroid prevention intervention - The adolescents training and learning to avoid steroids (ATLAS) program
    Goldberg, L
    Elliot, D
    Clarke, GN
    MacKinnon, DP
    Moe, E
    Zoref, L
    Green, C
    Wolf, SL
    Greffrath, E
    Miller, DJ
    Lapin, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (19): : 1555 - 1562
  • [10] Patient reporting of potential adverse drug reactions: a methodological study
    Jarernsiripornkul, N
    Krska, J
    Capps, PAG
    Richards, RME
    Lee, A
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (03) : 318 - 325